The 38^th Annual General Meeting of The IBN SINA Pharmaceutical Industry PLC is held today through Digital (Virtual) Platform.JanabKaziHarun or RashidHon’ble Chairman of the Company presided over the meeting.

A large number ofShareholders, Managing Director Prof. Dr. A. K. M Sadrul Islam including otherHon’bleDirectors, Chairman Audit Committee, Chairman NRC, Statutory Auditors, Compliance Auditors, Independent Scrutinizerand Company Secretary also attendedthe virtual AGM. The meeting started at 9:30 am by recitation from the Holy Quran.

The Directors’ Report, Auditors’ Report andAuditedFinancial Statementswere presented in the AGM for the Financial Year, 2021-22.

The AGM approved 60% Cash Dividend after evaluating the financial report for the Year-2021-22 of the Company.

Prof. Dr. A K MSadrul Islam, Managing Director delivered his speech and also replied to the Hon’ble Shareholders’ various questions.

Mr.KaziHarun or Rashid and Prof. Dr. AKM Sadrul Islam were re-elected as Director by rotation.

For better management and to make ease of operation of natural medicine production and sustainable growth of the Company,the AGMapproved the transfer of net asset of natural medicine division of the Company to the subsidiary Company “The IBN SINA Natural Medicine Ltd.” as a “Special Resolution”.

The Company had made a significant contribution in the year under reviewtowards the National Exchequers by paying Tk. 1,78,95,84,826/- (One Hundred SeventyEightCrore Ninety Five Lac Eighty Four Thousand Eight Hundred and Twenty Six) as Income Tax, VAT and other applicable Taxes.

As per Bangladesh Labour Laws, Company has transferred5% of the profit i.e. Tk. 4,03,41,605/- (Four Crore Three Lac Forty OneThousand SixHundred and Five)  to the Workers’ Profit Participation Fund (WPPF).

The meeting was ended with a vote of thanks to and from the Chairman of the Company by praying for the blessings of the Almighty Allah to the human being at large.

 On behalf of The IBN SINA Pharmaceutical Industry PLC,